| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |